Kedar Purushottam Phadke
Nessuna posizione attualmente
Profilo
Kedar Purushottam Phadke worked as a Secretary at Kirloskar Pneumatic Co. Ltd.
in 2009 and as a Secretary & Compliance Officer at Emcure Pharmaceuticals Ltd.
from 2010 to 2014.
He also worked as a Secretary & Compliance Officer at Thermax Ltd.
from 2017 to 2021.
Precedenti posizioni note di Kedar Purushottam Phadke
| Società | Posizione | Fine |
|---|---|---|
| THERMAX LIMITED | Responsabile della Conformità | 19/08/2021 |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Segretario Aziendale | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Consigliere Generale | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Aziende private | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Borsa valori
- Insiders
- Kedar Purushottam Phadke
